EPICS Congress Coverage: ASCO 2020 – Focus on Lung Cancer
Expert perspectives and strategic insights on the latest therapeutic developments and translational research in lung cancer treatment.
Faculty Members
Solange Peters, MD, PhD
Lausanne University Hospital, Lausanne, Switzerland
Nasser Hanna, MD
Indiana University School of Medicine, Indianapolis, IN, US
Jyoti Patel, MD, FASCO
Northwestern University Feinberg School of Medicine, Evanston, IL, US
David Spigel, MD
Sarah Cannon Research Institute Nashville, TN, US
Enriqueta Felip, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain
Julie Brahmer, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, US
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Immunotherapy: Stage IV NSCLC and Biomarker Research
- Immunotherapy and Targeted Agents in Stage I–III NSCLC
- Targeting Gene Fusions (ALK, RET, NTRK)
- Targeting Gene Mutations, Insertions, Amplifications (EGFR, MET, HER2, KRAS)
- New Approaches in Non-Small Cell Lung Cancer
- New Approaches in Small Cell Lung Cancer
